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Abstract Conventional procedures to assay RNA degra-
dation by a protein with ribonuclease (RNase) activity
require a step to isolate intact RNA molecules, which are
used as a substrate. Here, we established a novel ‘‘In-cell
RNA hydrolysis assay’’ in which RNAs within cells are
used as a substrate for the RNA-hydrolyzing protein,
thereby avoiding the need to prepare intact RNA mole-
cules. In this method, the degree of RNA degradation is
indicated by the fluorescence intensity of RNA molecules
released from fixed and permeabilized cells following
treatment with the potential RNase. A catalytic 3D8 anti-
body capable of degrading RNAs and pancreatic RNase A
were used as model RNases. Our data demonstrate that the
novel In-cell RNA hydrolysis assay is a reliable and sen-
sitive method to analyze the activities of potential RNA-
hydrolyzing proteins such as catalytic antibodies.
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Some anti-DNA antibodies that are found at high titers in
humans and mice with autoimmune diseases, such as sys-
temic lupus erythematosus and multiple sclerosis [1, 2], are
catalytic antibodies, also called abzymes, capable of
hydrolyzing DNA or RNA polymers [3–5]. It was reported
that polyclonal antibodies against DNA or RNA can
hydrolyze both molecules [6, 7]; however, it is unclear
whether these findings are due to the activity of a single
antibody that can hydrolyze both DNA and RNA or to the
activities of several antibodies that can each hydrolyze
DNA or RNA. Therefore, analysis of the RNA-hydrolyzing
activity of catalytic monoclonal anti-DNA antibodies
(more appropriately, catalytic anti-nucleic acid antibodies)
is important to understand the properties of these
antibodies.
Several methods have been developed to analyze the
DNA-hydrolyzing activity of catalytic anti-DNA antibod-
ies, in which plasmid DNA or synthetic nucleotides are
used as a substrate [8–12]. These methods can be used to
analyze the RNA-hydrolyzing capacity of proteins with
RNase activity, such as anti-DNA antibodies, simply by
substituting the DNA substrates (plasmid DNA or synthetic
deoxyribonucleotides) for RNA substrates (ribosomal RNA
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(rRNA) or synthetic ribonucleotides). We have previously
used in situ gel electrophoresis [13] and fluorescence res-
onance energy transfer-based analysis [14] to assay the
RNA-hydrolyzing activity of a catalytic 3D8 single-chain
variable fragment (scFv) antibody with DNA- and RNA-
hydrolyzing capacities. However, RNA molecules are
extremely vulnerable to degradation by RNases, and RNA
samples are often contaminated with these enzymes during
their preparation and storage, resulting in high background
in RNA hydrolysis assays.
Here, we developed an ‘‘In-cell RNA hydrolysis assay’’
in which RNA molecules within cells are used as a sub-
strate, thereby avoiding the need to isolate intact RNA
from cells or to synthesize RNA. Two proteins with RNase
activity, 3D8 scFv antibody and ribonuclease (RNase) A,
were used as model proteins to test this application. In this
assay, degradation of cellular RNAs is simply indicated by
the fluorescence intensity of RiboGreen-labeled RNA
molecules released from fixed and permeabilized cells
upon treatment with the RNase. This was verified by the
finding that the amount of RNAs inside fixed and perme-
abilized cells was decreased after treatment with an RNase.
The stringency of this method was confirmed by the finding
that cellular DNA did not affect the fluorescence intensity
of RiboGreen-labeled RNA. This assay provides a simple
means of determining the RNase activity of potential
RNases including catalytic antibodies.
Materials and Methods
Preparation of scFv Proteins
3D8 scFv and HW6 scFv proteins containing a protein-A
tag were purified from the supernatants of bacterial cultures
using IgG-Sepharose affinity chromatography [8].
Analysis of the Fluorescence Intensity of RiboGreen-
Labeled RNA Fragments
To detect cellular RNA fragments released from cells using
RiboGreen reagent, A549 human lung epithelial cells
grown at a density of 5 9 104 cells/well in a 48-well plate
were washed three times with ice-cold PBS and fixed with
4 % paraformaldehyde prepared in PBS for 15 min at room
temperature (RT). Cells were washed twice with PBS, and
cell membranes were permeabilized with P buffer (1 %
bovine serum albumin, 0.1 % saponin, and 0.1 % sodium
azide prepared in PBS) for 30 min at RT. Thereafter, cells
were treated with 100 ll of various concentrations of 3D8
scFv antibody, HW6 scFv antibody, or RNase A (Intron
Biotech) prepared in PBS containing 1 mM MgCl2 (pH
7.2) for 2 h at 37 C. Next, 50 ll of the conditioned
medium was added to microplate wells containing 100 ll
of Quant-iTTM RiboGreen reagent (Invitrogen, Cat. No.
R11490) diluted 200-fold with TE buffer (10 mM Tris–
HCl and 1 mM EDTA, pH 7.5) and incubated for 2 min at
RT in the dark. The reaction mixtures were excited at
485 nm and emission at 530 nm was measured using a
fluorescence analyzer.
In some cases, conditioned medium of fixed and per-
meabilized cells, pure 16S and 23S rRNA from E. Coli
(Invitrogen), or 1 lg/ml pUC19 plasmid DNA was incu-
bated with RiboGreen reagent in the absence or presence of
2 U DNase I (NEB) prepared in PBS containing 1 mM
MgCl2 (pH 7.2) or in DNase I reaction buffer (10 mM
Tris–HCl, 2.5 mM MgCl2, and 0.5 mM CaCl2, pH 7.6).
Analysis of RNA Fragments by Absorbance at 260 nm
(A260)
To detect cellular RNA fragments released from cells by
measuring ultraviolet (UV) light absorbance, A549 cells
grown at a density of 5 9 105 cells/well in a 6-well plate
were fixed and permeabilized as described above. There-
after, cells were treated with 500 ll of 10 lM RNase A or
3D8 scFv antibody prepared in PBS containing 1 mM
MgCl2 (pH 7.2) for 2 h at 37 C. Then, 150 ll of condi-
tioned medium from each well was applied to a protein
precipitation kit (National Diagnostics, Cat. No. EC-888)
to remove protein contaminants, and A260 was measured
using a UV spectrophotometer.
Confocal Microscopy
To analyze the level of RNA inside cells, confocal
microscopy was performed using a Click-iT RNA Alexa
Fluor 488 Imaging Kit (Molecular Probes). A549 cells
grown on coverslips (5 9 104 cells/well in a 24-well plate)
were incubated with 1 mM 5-ethynyl uridine (EU) for 20 h
at 37 C, allowing the incorporation of EU into newly
synthesized RNAs. Cells were fixed and permeabilized as
described above and then treated with 500 ll of 10 lM
RNase A or 3D8 scFv antibody prepared in PBS containing
1 mM MgCl2 (pH 7.2) for 2 h at 37 C. Cells were incu-
bated with Alexa 488-azide solution, which ligates EU, for
30 min at RT in the dark, and washed three times with
RNase-free PBS. Nuclei were stained with Hoechst 33342
(Vector Laboratories) for 30 min at RT. Images of intra-
cellular green fluorescence were acquired by confocal
microscopy (Carl Zeiss LSM 710).
Flow Cytometry
To detect cells containing fluorescent RNA molecules,
A549 cells (5 9 105 cells/well in a 6-well plate) were
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incubated with 1 mM EU for 20 h at 37 C and then
detached by trypsin treatment. Cells were washed, fixed,
and permeabilized as described for confocal microscopy
experiments. After treatment with 800 ll of 10 lM RNase
A or 3D8 scFv antibody prepared in PBS containing 1 mM
MgCl2 (pH 7.2) for 2 h at 37 C, cells were incubated with
Alexa 488-azide solution, which ligates EU, for 30 min at
RT and washed three times with RNase-free PBS. Finally,
cells were suspended in 4 % paraformaldehyde prepared in
PBS, and intracellular green RNA fluorescence was ana-
lyzed using a FACSCanto II flow cytometer (Becton–
Dickinson).
Results
RNA Degradation by a Potential RNase can be
Monitored Using the In-Cell RNA Hydrolysis Assay
When developing the novel In-cell RNA hydrolysis assay
using RiboGreen, we postulated that if cellular RNAs are
degraded by potential RNases in fixed and permeabilized
cells, cleaved small RNA fragments would be released
from the cells and could be detected using RiboGreen
reagent (Fig. 1). Fixed and permeabilized cells were
incubated with 3D8 scFv antibody, HW6 scFv antibody, or
RNase A, and then the level of RNA in the conditioned
medium was assessed in two ways (Fig. 2a): the fluores-
cence intensity of RiboGreen and A260.
RiboGreen binds to base-pairing nucleic acids and emits
green fluorescence signals, whereas free RiboGreen
exhibits negligible fluorescence in solution [15]. When
mixed with RiboGreen reagent, fluorescence signals were
not detected in the conditioned medium of cells treated
with RNase A or 3D8 scFv antibody, which can hydrolyze
RNA (Fig. 2b). Fluorescence signals were detected when
RiboGreen was mixed with intact rRNA, but not when it
was mixed with rRNA that had been completely degraded
by RNase A (Fig. 2c). Based on this finding, we speculated
that complete degradation of RNA by RNase A or 3D8
scFv antibody can perturb the formation of intrastrand
base-pairs to which RiboGreen binds, resulting in an
undetectable fluorescence signal. Strong fluorescence was
observed in negative controls (untreated cells and cells
treated with HW6 scFv antibody, which does not cleave
RNA) (Fig. 2b). Such fluorescence signals in negative
control samples suggest that some RNA molecules are
small enough to be released from permeabilized cells even
in the absence of an RNase.
Direct evidence for the release of small RNA fragments
upon degradation by RNase A or 3D8 scFv antibody is
supported by the measurement of A260 in conditioned
medium. A260 is proportional to the total amount of RNA
or bases, regardless of the integrity of the RNA molecules.
The A260 of conditioned medium from which proteins had
been removed using a protein precipitation kit was inver-
sely proportional to the fluorescence intensity of Ribo-
Green in the corresponding samples (Fig. 2d). These A260
values were significantly increased when fixed and per-
meabilized cells were treated with RNase A or 3D8 scFv
antibody, suggesting that RNAs are easily released from
these cells when they are degraded by RNases. A260 was
negligible in untreated and HW6 scFv antibody-treated
samples, which is inconsistent with the strong signal shown
in Fig. 2b. This can be explained by differences in assay
sensitivity; the RiboGreen assay is *1,000-fold more
sensitive than A260 measurements. The sensitivities of the
RiboGreen and A260 assays are approximately 1 ng/ml and
4 lg/ml RNA in solution, respectively, according to the
manufacturer’s guide.
Fig. 1 Schematic representation of the concept of the In-cell RNA
hydrolysis assay. a Cells containing intact RNAs. b Cells whose
membranes have been permeabilized, allowing the release of small
RNA fragments even in the absence of RNase treatment. c Cells
release small RNA fragments via their membrane pores following
treatment with an RNase. d Collection of degraded RNA fragments
released from cells, which are labeled with RiboGreen and subjected
to fluorescence intensity measurement
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To improve the reliability of the In-cell RNA hydrolysis
assay using RiboGreen, it was necessary to rule out the
possibility that DNA molecules interfere with the results
because RiboGreen can bind single-stranded and double-
stranded DNA, in addition to RNA. The effect of DNA on
RiboGreen fluorescence was examined in DNase I reaction
buffer because DNase I works in this buffer containing
CaCl2 but not in PBS containing 1 mM MgCl2 (Fig. 2e).
The fluorescence intensity of RiboGreen in the conditioned
medium of cells treated with RNase A or 3D8 scFv anti-
body was similar in the presence and absence of DNase I.
This suggests that DNA does not affect the detection of
RNA by RiboGreen in this assay (Fig. 2f). Taken together,
these data show that potential RNases enter fixed and
permeabilized cells and degrade RNA into fragments that
are small enough to be released from cells through mem-
brane pores, thereby allowing RNA degradation to be
monitored.
RNA is Degraded in an RNase Concentration-
Dependent Manner
RNA degradation in fixed and permeabilized cells treated
with various concentrations of proteins was quantitatively
analyzed. A standard curve was generated using pure 16S
and 23S rRNA to calculate the concentration of RNA
released from fixed and permeabilized cells upon treatment
with an RNase (Fig. 3a). In the absence of RNase treat-
ment, 100 ll of conditioned medium from a single well of
a 48-well plate (5 9 104 cells/well) contained *400 ng of
RNA. This supports the observation that RNA released
from untreated cells in a 48-well plate could not be
detected by measurement of A260 but was detected by
RiboGreen labeling (Fig. 2). The degradation of RNA
molecules, as detected by RiboGreen fluorescence in con-
ditioned medium, increased in an RNase A dose- and 3D8
scFv antibody dose-dependent manner (Fig. 3b). In total,
Fig. 2 The detection of RNAs released from fixed and permeabilized
cells. a Experimental procedures for the data presented in (b) and (d).
b A549 cells grown in a 48-well plate at a density of 5 9 104 cells/
well were fixed, permeabilized, and incubated with 100 ll of 10 lM
RNase A or 10 lM 3D8 antibody for 2 h at 37 C. An aliquot of the
conditioned medium was added to RiboGreen, and the fluorescence
intensity was analyzed. c Pure 16S and 23S rRNA from E. coli was
incubated with RiboGreen in the presence or absence of RNase A
prior to fluorescence intensity analysis. d A549 cells grown in a
6-well plate at a density of 5 9 105 cells/well were fixed, permeabi-
lized, and incubated with 10 lM RNase A or 3D8 antibody for 2 h at
37 C. Proteins were removed from the conditioned medium by
precipitation, and absorbance at 260 nm was measured. e Degradation
of plasmid DNA (1 lg/ml) by DNase I (2 U) was tested using
RiboGreen prepared in DNase I reaction buffer for 2 h at 37 C.
f Fixed and permeabilized cells in a 48-well plate were treated with
RNase A or 3D8 antibody (10 lM) in the presence or absence of
DNase I (2 U) for 2 h at 37 C. The conditioned medium was mixed
with RiboGreen prior to fluorescence intensity analysis. RFU relative
fluorescence unit. Data represent the mean ± standard error of four
independent experiments
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100 ll of 10 lM 3D8 scFv antibody, 10 lM HW6 scFv
antibody, and 10 lM RNase A corresponds to 3.7, 3.7, and
1.3 lg of protein, respectively.
Furthermore, the sensitivity of our method was assessed
with RNase A. RNase A was diluted to various concen-
trations from a stock solution of 1 lM, and then 100 ll of
each dilution was incubated with fixed and permeabilized
cells, prior to detection of the RiboGreen signal. RNA
hydrolysis was detectable with 3.91 nM RNase A (Fig. 3c),
indicating a sensitivity of *5 ng (100 ll of 3.91 nM
RNase A corresponds to 5.4 ng of protein). This method
seems to be *400-fold more sensitive than the traditional
in situ gel electrophoresis-based method [13], which
requires *2 lg of protein. Therefore, it should be possible
to assay the activities of RNase candidates that are lowly
abundant using this assay.
Verification of the Principle of the In-Cell RNA
Hydrolysis Assay by the Reduction in the Level
of Intracellular RNA Following RNase Treatment
To verify the principle of the In-cell RNA hydrolysis assay,
we examined whether the amount of RNA within cells
decreased as RNA was released. Cells were incubated with
EU, which is actively incorporated into nascent RNAs in
the nucleus, fixed, permeabilized, and treated with RNase
A or 3D8 scFv antibody. Following labeling of EU-incor-
porated RNAs with Alexa 488-azide, RNA remaining
inside cells was analyzed by confocal microscopy (Fig. 4a)
and flow cytometry (Fig. 4b). The fluorescence intensity of
RNA inside fixed and permeabilized cells treated with
RNase A or 3D8 scFv antibody was dramatically
decreased, in comparison with levels inside negative con-
trol cells. This was indeed due to the release of degraded
RNA from cells. This verifies the principle of the In-cell
RNA hydrolysis assay i.e., RNA inside cells can be used as
a substrate for a potential RNase.
Discussion
We established the novel In-cell RNA hydrolysis assay. This
assay was designed to detect the release of degraded RNA
generated by a RNA-hydrolyzing protein from fixed and
permeabilized cells using RiboGreen, an ultrasensitive
reagent to RNA in solution. We expected that the fluores-
cence intensity of RiboGreen would be directly proportional
to the amount of RNA fragments released from permeabi-
lized and fixed cells treated with an RNase; however, the
fluorescence intensity of RiboGreen was decreased by
treatment with an RNase due to the complete degradation of
RNA molecules such that they were no longer recognized by
RiboGreen (Fig. 2b). Therefore, this assay detects the
reduction in the level of intact RNA molecules in RNase-
treated cells, in comparison with the basal level in untreated
cells. This assay is simple and requires neither RNAs puri-
fied from cells nor artificially synthesized RNA molecules to
be used as substrates for potential RNases. Moreover, it does
not require a DNase treatment step to improve its reliability,
even though RiboGreen can bind both RNA and DNA. The
fluorescence intensity of RiboGreen was similar in the pre-
sence and absence of DNase I (Fig. 2f). DNA molecules
packaged into chromatin in the nucleus would not be
attacked by a protein with DNA- and RNA-hydrolyzing
activities, such as 3D8 scFv antibody; therefore, the majority
of RiboGreen fluorescence in this assay can be attributed to
RNA, not to DNA.
Cells were fixed with 4 % paraformaldehyde and per-
meabilized with 0.1 % saponin. Paraformaldehyde is a
protein-crosslinking fixative that creates covalent bonds
Fig. 3 Quantitative analysis of RNA degradation in fixed and
permeabilized cells treated with RNase A or 3D8 antibody. a Standard
curve to determine the concentration of RNA. Pure rRNA at known
concentrations was mixed with RiboGreen prior to fluorescence
intensity analysis. b Dose-dependent RNA degradation. RNA degra-
dation was quantitatively analyzed in fixed and permeabilized cells
(5 9 104 cells) treated with 1.25–10 lM RNase A or 3D8 antibody.
c The sensitivity of this method. RNA degradation was quantitatively
analyzed in fixed and permeabilized cells treated with various
dilutions of RNase A generated from a stock solution of 1 lM. RFU,
relative fluorescence unit. Data represent the mean ± standard error
of four independent experiments
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between proteins, primarily residues of the basic amino
acid lysine, without affecting nucleic acids. This indicates
that nucleic acids can be freely released from fixed cells,
while the majority of proteins would be retained [16].
Saponin generates pores on membranes by forming com-
plexes with cholesterol in the membrane [17]. Treatment
with saponin generates pores in cell membranes through
which small nucleic acids can passively diffuse; however,
it does not permeabilize the inner nuclear envelope and the
mitochondrial membrane, which lack cholesterol. Saponin
generates pores with a diameter of approximately 8 nm
[18]. Given that molecules larger than 100 kD cannot pass
through pores with a diameter of 10 nm [19], it seems that
RNAs shorter than *250 nt were released from fixed and
permeabilized cells in the absence of RNase treatment, and
these short RNAs underlie the RiboGreen fluorescence
detected in negative control samples in Fig. 2.
The level of RNA in nuclei was dramatically reduced in
cells treated with RNase A or 3D8 scFv antibody (Fig. 4b).
This could be because the main target of these RNases is
naked rRNAs in nuclei, including 45S (13.7 kb) pre-rRNA,
28S (5,070 nt) rRNA, 18S (1,869 nt) rRNA, 5.8S (156 nt)
rRNA, and 5S (121 nt) rRNA, which are yet to assemble
with proteins into ribosomes. rRNAs comprise approxi-
mately 80 % of total RNA in eukaryotic cells, while mRNAs
and tRNAs (*75–90 nt) comprise approximately 5 and
15 %, respectively [20]. RNase A (14 kD) and 3D8 scFv
antibody (34 kD) likely entered the nucleus via nuclear
pores to attack rRNAs. The diameter of the nuclear pore is
approximately 9 nm [19]. Therefore, RNA fragments of less
than*300 nt can be released from the nucleus, even though
saponin does not affect the nuclear membrane. There was a
marked basal level of small intact RNAs released from fixed,
untreated cells (Fig. 2b). Although the experiment shown in
Fig. 4 sought to verify the principle of the In-cell RNA
hydrolysis assay, it could also be used as another method to
assay RNA degradation.
Our study demonstrates that the In-cell RNA hydrolysis
assay can be a useful alternative method to analyze RNase
activity.
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